Institutional investors purchased a net $767.6 thousand shares of VICL during the quarter ended December 2014, and now own 37.82% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OXFORD ASSET MANAGEMENT LLP Sold 22.3 Thousand shares of Vical Inc